Strategic Expansion ATCC is investing $54.7 million to expand its bioresource center campus in Virginia with a new biomanufacturing facility focused on global health, signaling capacity growth and potential demand for additional materials, equipment, and contract services.

Leadership Stability Appointment of Ruth R. Cheng as president and CEO in January 2025 presents an opportunity to align strategic initiatives and pursue new partnerships, joint ventures, and funding opportunities in sustainable health and research infrastructure.

Scale & Reach As the world’s largest and most diverse collection of biological reference materials and data, ATCC’s extensive catalog and standards leadership create multiple upsell paths for validated cell lines, microorganisms, and associated data services to academia, industry, and government.

Digital & Data Assets With tech tools like JMP, Power Apps, Dynamics AX, HubSpot, and data-centric offerings, there are opportunities to cross-sell data management, analytics, and CRM-enabled procurement solutions to streamline sourcing, compliance, and reporting for researchers.

Public Health Focus Global health-oriented biomanufacturing expansion and assay-ready cell offerings position ATCC to partner on translational medicine, drug discovery, and public health initiatives, including custom materials sourcing, assay development, and collaborative research programs.